Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2011
09/28/2011CN102000249B Medicament for treating tinea of feet and hands
09/28/2011CN101966249B Bromhidrosis cleaning spraying agent
09/28/2011CN101961363B Preparation method of active pseudo-ginseng slices
09/28/2011CN101954058B Medicament for treating pernio
09/28/2011CN101947253B External compound preparation for curing tinea corporis as well as preparation method and content measuring method thereof
09/28/2011CN101934021B Preparation method of traditional Chinese medicinal lotion for treating bedsore
09/28/2011CN101912559B Kidney-activating traditional Chinese medical pill capable of tonifying kidney, strengthening yang, maintaining beauty and treating infertility
09/28/2011CN101904948B Traditional Chinese medicine preparation of new Zhongsheng pill and preparation method thereof
09/28/2011CN101904817B Cefsulodin sodium liposome injection
09/28/2011CN101891738B Dasatinib polymorph and preparation method and medical composition thereof
09/28/2011CN101843778B Chinese medicament for treating ichthyosis
09/28/2011CN101843771B Chinese medicament for treating ichthyosis
09/28/2011CN101837094B External Chinese medicinal preparation for curing bedsore
09/28/2011CN101785836B Traditional Chinese medicine ointment, preparation method and application thereof for skin disease treatment
09/28/2011CN101757223B Externally-applied traditional Chinese medicine for treating psoriasis
09/28/2011CN101744902B Medicament for treating burns, traumatic hemorrhage and preparation method thereof
09/28/2011CN101732227B Composition for nourishing hair follicle, preventing hair drop and fixing hair and manufacturing method thereof
09/28/2011CN101637512B Traditional Chinese medicine preparation for treating vitiligo
09/28/2011CN101632774B Quality control method for Keyin pills
09/28/2011CN101632646B Olopatadine hydrochloride tablet as well as preparation method and detecting method thereof
09/28/2011CN101485814B Supercritical CO2 extraction method for saponin component in Paris polyphylla var. yunnanensis
09/28/2011CN101417121B Medicine capable of curing skin burning and freezing injury
09/28/2011CN101380349B Specific ointment for burn and scald
09/28/2011CN101297956B Medicine for treating empyrosis and eczema and producing method thereof
09/28/2011CN101214299B Spray coating type empyrosis medicinal liquor and preparation thereof
09/28/2011CN101185729B Fumigation and cleaning medicine for treating psoriasis
09/28/2011CN101181425B Chinese medicine externally used liniment
09/28/2011CN101181250B Antimicrobial compounds
09/28/2011CN101039695B Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
09/27/2011USRE42755 Honey based wound dressing
09/27/2011US8026268 Method for scavenging radicals with urocanic acid, derivatives and analogues
09/27/2011US8026236 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
09/27/2011US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
09/27/2011US8025893 Cyclopamine can be used for obtaining decrease of pigmentation of hyperpigmented skin areas
09/27/2011US8025892 Cosmetic particulate gel carriers for topically applied active agents
09/27/2011US8025883 Antagonists and methods for inhibiting angiogenesis
09/27/2011CA2506476C Method of treatment of myocardial infarction
09/27/2011CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
09/27/2011CA2467723C Method for treating cervical cancer
09/27/2011CA2440630C Metalloproteinase inhibitors
09/27/2011CA2400462C Aspirin-triggered lipid mediators
09/27/2011CA2396809C Water-soluble ginger root extract
09/27/2011CA2377519C Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
09/27/2011CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion
09/27/2011CA2336218C Neurotrophic factors
09/27/2011CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
09/27/2011CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies
09/22/2011WO2011116216A2 Topical skin care composition
09/22/2011WO2011115700A2 Emollient foams for treatment of seborrheic dermatitis
09/22/2011WO2011115272A1 Proteoglycan-containing microneedle array
09/22/2011WO2011115183A1 Novel monocyclic pyrimidine derivative
09/22/2011WO2011115173A1 Monomaleate of benzothiazine compound
09/22/2011WO2011115088A1 Human dermal epithelial cell growth promoter, and skin composition for external use and cosmetic material including the same
09/22/2011WO2011115061A1 Hyaluronic acid production promoter
09/22/2011WO2011114645A1 Anti-allergic composition
09/22/2011WO2011113969A1 Cream for burns
09/22/2011WO2011113826A1 Novel topical corticosteroid formulation
09/22/2011WO2011113802A2 Imidazopyridine compounds, compositions and methods of use
09/22/2011WO2011113507A2 Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
09/22/2011WO2011113151A1 Extracts and compounds from ficus benghalensis for increasing hair growth and decreasing hair loss
09/22/2011WO2011059776A3 Prophylaxis of skin cancer with retinamides
09/22/2011US20110230811 Patterned gradient wound dressing and methods of using same to promote wound healing
09/22/2011US20110230566 Perfluorocarbon eye cream formulations
09/22/2011US20110230557 Polyunsaturated fatty acid and diol ester as an anti-acne agent
09/22/2011US20110230556 Diglycidic Ether Derivative Therapeutics and Methods for Their Use
09/22/2011US20110230555 Enzyme Inhibitors and the Use Thereof
09/22/2011US20110230539 Small Molecule Inhibitors of N-Terminus Activation of the Androgen Receptor
09/22/2011US20110230536 Phenylpyrazole inhibitors of store operated calcium release
09/22/2011US20110230521 Pyrazole Compounds As CCR1 Antagonists
09/22/2011US20110230516 CCR1 Antagonists and Methods of Use Therefor
09/22/2011US20110230503 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions
09/22/2011US20110230499 Hsp90 inhibitors for therapeutic treatment
09/22/2011US20110230487 Arylsulfonamide ccr3 antagonists
09/22/2011US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors
09/22/2011US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent
09/22/2011US20110230479 Neurotrophin mimetics and uses thereof
09/22/2011US20110230474 Topical antimicrobial compositions and methods of using same
09/22/2011US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors
09/22/2011US20110230462 Pyrrolopyrazine Kinase Inhibitors
09/22/2011US20110230459 Lactam acetamides as calcium channel blockers
09/22/2011US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof
09/22/2011US20110230448 Treatment and/or Prevention of Non-Viral Epithelial Damage
09/22/2011US20110230444 Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor
09/22/2011US20110230438 Viscoelastic gel for dermatological use
09/22/2011US20110230417 Treatment of diseases and conditions mediated by increased phosphorylation
09/22/2011US20110230415 Pharmaceutical Composition Containing GHRP-6 To Prevent And Eliminate Fibrosis And Other Pathological Deposits In Tissues
09/22/2011US20110230411 Albumin fibers and fabrics and methods of generating and using same
09/22/2011US20110230400 Nutritional composition for wound healing
09/22/2011US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
09/22/2011US20110229583 Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid
09/22/2011US20110229577 Biologically active silicic acid
09/22/2011US20110229575 Deep immersion flotation therapy for burn victims
09/22/2011US20110229574 Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
09/22/2011US20110229568 Michael systems as transglutaminase inhibitors
09/22/2011US20110229538 Topical skin care composition
09/22/2011US20110229536 Compositions for topical application comprising microencapsulated colorants
09/22/2011US20110229496 Method for regulating survival and memory of t helper 1 cells
09/22/2011US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies
09/22/2011US20110229476 Monospecific and multispecific antibodies and method of use
09/22/2011US20110229475 Novel compounds